Azitra (AZTR) Interest Coverage Ratio (2022 - 2026)
Azitra (AZTR) reported Interest Coverage Ratio of 1143.36 for Q1 2026, up 52.31% on a YoY basis from 750.66 in Q1 2025, and down 175.93% quarter-over-quarter from 414.36 in Q4 2025.
Azitra (AZTR) Interest Coverage Ratio (2022 - 2026) Analysis & Trends
Azitra has reported Interest Coverage Ratio for 5 years, with the latest figure at 1143.36 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio rose 52.31% year-over-year to 1143.36; the trailing twelve-month figure through Mar 2026 stood at 1215.84 (down 37.04% YoY), and the FY2025 full-year result was 1449.85, down 60.49% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 1143.36, down from 414.36 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 14.58 in Q4 2022, with the low at 7442.16 in Q3 2025.
- Historically, Interest Coverage Ratio has averaged 1813.57 across 5 years, with a median of 952.0 in 2024.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio surged 87.35% — and 2024, when it plunged 18552.87%.
- Azitra's Interest Coverage Ratio stood at 14.58 in 2022, then plunged by 16900.39% to 2477.91 in 2023, then soared by 82.5% to 433.74 in 2024, then advanced by 4.47% to 414.36 in 2025, then tumbled by 175.93% to 1143.36 in 2026.
- The last three Interest Coverage Ratio figures came in at 1143.36 (Q1 2026), 414.36 (Q4 2025), and 7442.16 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Azitra | 20,900.00 | 20,900.00 | - | -1,143.36 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,143.36 |
| Dec 31, 2025 | -414.36 |
| Sep 30, 2025 | -7,442.16 |
| Jun 30, 2025 | -6,135.37 |
| Mar 31, 2025 | -2,397.71 |
| Dec 31, 2024 | -433.74 |
| Sep 30, 2024 | -760.64 |
| Jun 30, 2024 | -1,492.86 |
| Mar 31, 2024 | -3,236.61 |
| Dec 31, 2023 | -2,477.91 |
| Sep 30, 2023 | -2,808.07 |
| Jun 30, 2023 | -18.74 |
| Mar 31, 2023 | -17.35 |
| Dec 31, 2022 | -14.58 |
| Sep 30, 2022 | -75.65 |
| Jun 30, 2022 | -148.08 |